Infographic: How Does the ACA Impact Premiums? It Depends.
Time For Affordability
Friday, February 21, 2014
The health care reform law will expand access to insurance and broaden insurance benefits. Everyone can sign up, including those with pre-existing medical conditions. These new benefits bring new costs. Financial assistance will be available to help qualifying individuals and families pay for coverage. Even with this new assistance, the new benefits will cause many people who currently have insurance to pay more than they do today.
A Senate hearing on Wednesday into the staggering cost of specialty drugs to treat the deadly Hepatitis C virus has once again raised the question of how far the government should go to try to beat down pharmaceutical costs without discouraging research and development or creating drug shortages.
Rhode Island’s Medicaid program decided in September to ration the delivery of Sovaldi, a prescription drug approved by the U.S. Food and Drug Administration last year to cure chronic Hepatitis C, due to the drug’s high cost and the relatively high prevalence of the virus among Medicaid enrollees in the state.
The first thing Philip Mason noticed was the hair loss. The 73-year-old retiree, a former computer programmer, began shedding hair from his arms, legs, everywhere on his body. “It just all came right off,” he said.
It’s been almost a year since federal regulators approved a new hepatitis C treatment that costs about $1,000 per pill. But time hasn’t done much to ease concerns of state officials who worry about the drug’s budget-busting potential.
When physicians and administrators at Christiana Care Health System in Wilmington, Del., saw how many newly approved specialty and orphan drugs had price tags in the tens of thousands of dollars, they decided in 2011 to form a committee that uses a 20-point scoring system to decide if a drug should be listed on the system's formulary.